Novo Nordisk has launched its weight-loss drug Wegovy in China after it was approved by local health authorities in June. It ...

New data shows that government-funded health insurance plans in the United States provide the majority of coverage for ...

State Medicaid programs for low-income families are the single biggest source of coverage, giving 31.6 million people access ...

State Medicaid programs for low-income families are the single biggest source of coverage, giving 31.6 million people access ...

Research shows that 1 in 8 adults in the US has used one of the popular GLP-1 medications, most of them trying to manage ...

The best online providers offer strong support services to help you succeed in your GLP-1 weight loss journey.

Kennedy Jr., who has been tapped by Trump to lead the HHS, has been critical of Ozempic and other weight loss drugs.

Researchers looked at the health records of 17 million Americans with obesity and determined that between 2022 and 2023, ...

Novo Nordisk gained approval for Wegovy in China in June, and will initially target Chinese patients willing to pay ...

More than half of all American adults, almost 137 million people, could be candidates for the blockbuster GLP-1 drug ...

Join the debate on weight loss drugs at NAILBA 43. Experts discuss the risk factors and effectiveness of GLP-1 drugs like Ozempic.